Edy Hasrouni
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 15
- Acute Myeloid Leukemia Research 14
- Chronic Myeloid Leukemia Treatments 3
- Genetics 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Blood disorders and treatments 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Mikkael A. Sekeres (15 shared papers)Ramón V. Tiu (15 shared papers)Ali Tabarroki (15 shared papers)Valeria Visconte (15 shared papers)Edward A. Copelan (6 shared papers)Yogen Saunthararajah (6 shared papers)Fabı́ola Traina (3 shared papers)Anjali S. Advani (5 shared papers)
- Journals
- Blood (8 papers)Leukemia (2 papers)Journal of Clinical Oncology (1 paper)American Journal of Hematology (1 paper)Development (1 paper)
- Partner nations
- United StatesBrazilJapan
In The Last Decade
Edy Hasrouni
15 papers receiving 371 citations
Peers
Comparison fields: 5 of 36
- Hematology 264
- Genetics 108
- Molecular Biology 225
- Cancer Research 43
- Pathology and Forensic Medicine 20
Countries citing papers authored by Edy Hasrouni
This map shows the geographic impact of Edy Hasrouni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edy Hasrouni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edy Hasrouni more than expected).
Fields of papers citing papers by Edy Hasrouni
This network shows the impact of papers produced by Edy Hasrouni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edy Hasrouni. The network helps show where Edy Hasrouni may publish in the future.
Co-authors
The 25 scholars most cited alongside Edy Hasrouni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 219 | |
| 2 | 2012 | 54 | |
| 3 | 2014 | 48 | |
| 4 | 2014 | 17 | |
| 5 | 2016 | 14 | |
| 6 | 2013 | 4 | |
| 7 | 2012 | 4 | |
| 8 | 2013 | 3 | |
| 9 | 2012 | 3 | |
| 10 | 2012 | 2 | |
| 11 | 2013 | 2 | |
| 12 | 2011 | 1 | |
| 13 | 2015 | 1 | |
| 14 | 2013 | 1 | |
| 15 | 2013 | 1 | |
| 16 | 2012 | 0 | |
| 17 | 2013 | 0 |
About Edy Hasrouni
Edy Hasrouni is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Surgery, having authored 17 papers that have together received 374 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Chronic Myeloid Leukemia Treatments (3 papers), Pancreatic function and diabetes (2 papers), Blood disorders and treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), RNA modifications and cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Hematology (264 citations), Genetics (108 citations), Molecular Biology (225 citations), Cancer Research (43 citations) and Pathology and Forensic Medicine (20 citations). Edy Hasrouni has collaborated with scholars based in United States, Brazil and Japan. Frequent co-authors include Mikkael A. Sekeres, Ramón V. Tiu, Ali Tabarroki, Valeria Visconte, Edward A. Copelan, Yogen Saunthararajah, Fabı́ola Traina, Anjali S. Advani, Hideki Makishima and Sara Teresinha Olalla Saad. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, American Journal of Hematology and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.